New research has demonstrated the effectiveness of a first-in-class oral, non-hormonal drug in increasing embryo implantation, pregnancy and live birth rates among infertile women who are undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). The findings, presented at the ESHRE 40th Annual Meeting in Amsterdam, represent a significant step toward the first therapeutic tool to increase embryo implantation and live birth rate success. The study abstract was published in Human Reproduction. Worldwide, one in six people of reproductive age experience infertility in their lifetime. Over 3 million IVF Read More
Novel treatment improves embryo implantation and live birth rates in infertile women undergoing IVF and ICSI
New research has demonstrated the effectiveness of a first-in-class oral, non-hormonal drug in increasing embryo implantation, pregnancy and live birth rates among infertile women who are undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). The findings, presented at the ESHRE 40th Annual Meeting in Amsterdam, represent a significant step toward the first therapeutic tool to increase embryo implantation and live birth rate success. The study abstract was published in Human Reproduction. Worldwide, one in six people of reproductive age experience infertility in their lifetime. Over 3 million IVF Read More